• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
SELB

SELB

Selecta Biosciences, Inc.

NASDAQHealthcareBiotechnologyUS

USD0.88

-0.08 (-8.00%)

Company Profile

CEO

Carsten Brunn

IPO Date

2016-06-22

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.89

Prev. Close

$0.96

Day Low

$0.81

Day High

$0.94

52W Low

$0.79

52W High

$1.99

Market Cap

$0.14B

Volume

2.76M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

10

Avg Positive

14.0%

Avg Negative

20.6%

Avg Neutral

65.4%

News Feed

Selecta Biosciences to Participate at the William Blair Biotech Focus Conference 2021

GlobeNewsWire·7/8/2021·↑ positive

Selecta Biosciences Has Multiple Shots On Goal

Seeking Alpha·6/28/2021·↑ positive

Selecta Biosciences Appoints Industry Leader Nishan de Silva, M.D. to Board of Directors

GlobeNewsWire·6/24/2021·↑ positive

Selecta Biosciences to Participate at the Raymond James Human Health Innovation Conference

GlobeNewsWire·6/16/2021·↑ positive

Selecta Biosciences, Inc. (SELB) CEO Carsten Brunn on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/13/2021·↓ negative

Selecta Biosciences, Inc. (SELB) Reports Q1 Loss, Tops Revenue Estimates

Zacks Investment Research·5/13/2021·↑ positive

Recap: Selecta Biosciences Q1 Earnings

Benzinga·5/13/2021·↓ negative

Why Selecta Biosciences Stock Is Dropping Today

The Motley Fool·4/29/2021·↓ negative

Selecta Biosciences Stock Is Trading Lower After Gaining Total Rights To MMA Program From AskBio

Benzinga·4/29/2021·↑ positive

Selecta Biosciences and AskBio Announce Updates to Methylmalonic Acidemia (MMA-101) Program

GlobeNewsWire·4/29/2021·↑ positive